SEC Company Response from Carlyle Group (CG) — May 19, 2017
Carlyle Group Inc.
Date: May 19, 2017 · CIK: 0001527166 · Accession: 0001193125-17-176241
AI Filing Summary & Sentiment
File numbers found in text: 001-35538
Referenced dates: May 3, 2017
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
SIMPSON THACHER & BARTLETT
LLP
900 G STREET, NW
WASHINGTON, D.C. 20001
(202) 636-5500
FACSIMILE (202) 636-5502
DIRECT DIAL NUMBER
E-MAIL ADDRESS
202-636-5804
jbonnie@stblaw.com
VIA EDGAR
May 19, 2017
Re:
The Carlyle Group L.P.
Form 10-K for the Fiscal Year Ended December 31, 2016
Filed February 16, 2017
Form 8-K
Furnished February 8, 2017
File No. 001-35538
Mr. Hugh West
Accounting
Branch Chief
Office of Financial Services
Securities and
Exchange Commission
100 F Street, N.E.
Washington, D.C.
20549
Dear Mr. West:
On behalf of
The Carlyle Group L.P., we hereby submit the following responses to the comment letter issued by the Securities and Exchange Commission Staff dated May 3, 2017 regarding the Staff’s review of Carlyle’s Form 10-K for the Fiscal Year Ended December 31, 2016 filed on February 16, 2017 and Form 8-K furnished on February 8, 2017.
To assist your review, we have retyped the text of the Staff’s comments in italics below. The responses and information described below
are based upon information provided to us by Carlyle.
Form 10-K for the Fiscal Year Ended December 31,
2016
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Recent Transactions, page 88
1.
We note your disclosure of transactions with Claren Road, ESG and the DGAM Restructuring during 2016. Please address the following:
•
Confirm that the Partnership did not receive anything in exchange for the transfer of interests in Claren Road and ESG.
NEW YORK BEIJING HONG
KONG HOUSTON LONDON LOS ANGELES PALO ALTO
SÃO PAULO SEOUL TOKYO
Securities and Exchange Commission
•
Tell us the economic substance and benefit the Partnership expects to receive as a result of these transactions.
•
In future filings, clearly disclose how the aggregate impact of these transactions impact revenues and income from continuing operations. Refer to Item 303(a)(3)(ii) of Regulation
S-K.
In February 2016, Carlyle decided to wind down the business conducted by DGAM, a hedge fund-of-funds investment advisor acquired by Carlyle in 2014. Subsequently, in the third quarter of 2016, Carlyle decided to wind down or transfer its interests in Claren
Road, ESG and Vermillion, the hedge fund investment advisors in which Carlyle previously had acquired joint venture interests. Carlyle’s decisions to terminate its interests in each of these hedge fund advisory businesses was based on the poor
investment performance of the underlying hedge funds managed by these investment advisors and the substantial investor redemptions suffered by the underlying hedge funds. At the time of the decisions to pursue a wind down or disposition, the
relevant hedge fund investment advisors were not making significant contributions to Carlyle’s AUM, revenue or income from continuing operations. DGAM, Claren Road and Vermillion actually had generated immaterial losses for Carlyle at the time
of such decisions.1
The founders of Claren
Road and ESG were willing to continue operating their hedge fund businesses, and Carlyle therefore negotiated the transfer of its interests in Claren Road and ESG back to their respective founders. In exchange for the transfers of its interests back
to the Claren Road and ESG founders, Carlyle received relief from certain future obligations as disclosed in Note 11 to the Consolidated Financial Statements in Item 8. of Carlyle’s Form 10-K for the
Fiscal Year Ended December 31, 2016. Carlyle did not receive any future benefits in exchange for the transfer of these interests other than a minority profit interest in the ESG investment advisor’s annual net income through 2020, which
Carlyle will account for as contingent consideration received by a seller if and when all contingencies are resolved. Carlyle believes this contingent interest will be immaterial to future results of operations.
In Item 7. MD&A of Carlyle’s Form 10-K for the Fiscal Year ended December 31, 2016, Carlyle discussed
the wind down of DGAM (for example, on pages 149-150 and page 222) and the transfers or wind down of the hedge funds (for example, on page 139, page 141, and pages
221-222) where these impacted certain of the revenues and expenses of Carlyle or the respective Investment Solutions or Global Market Strategies segments. In future quarterly and annual filings, Carlyle will
disclose clearly the consolidated impact of these transactions on revenues and income from continuing operations to the extent material and will also continue to provide discussion as appropriate to the extent that these transactions result in
notable year-over-year changes in specific revenues or expenses of the impacted segments.
1
The decision to wind down the operations of DGAM was disclosed in Notes 3 (page 195) and 7 (page 213) to the Consolidated Financial Statements in Item 8. of Carlyle’s Form
10-K for the Fiscal Year Ended December 31, 2015. Carlyle disclosed that it was conducting a strategic review of its hedge fund businesses in Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations (“MD&A”) in its quarterly report on Form 10-Q for the quarter ended September 30, 2016 (page 116).
2
Securities and Exchange Commission
2.
We also note that during 2016, you decided to wind down the commodities products that were offered through Vermillion. During your fourth quarter earnings call and on page 220, this was highlighted as an area that
was negatively impacted in 2016 with a net amount of $150 million attributable to losses from certain funds and vehicles associated with Vermillion Asset Management. Please address the following in your future filings:
•
Expand to disclose the factors contributing to the losses from those certain funds and vehicles associated with Vermillion Asset Management to the extent it is related to your decision to wind down the commodities
products offered.
•
Quantify the remaining exposure the Partnership has associated with the existing commodities products offered through Vermillion.
•
Clearly disclose how the impact of this wind down impacts revenues and income from continuing operations. Refer to Item 303(a)(3)(ii) of Regulation S-K.
Similar to the decision to wind down the DGAM operations, Carlyle also initiated a wind down of the commodities hedge fund operations in the third quarter of
2016 and ceased the pursuit of new investment opportunities for funds advised by Vermillion. None of Vermillion’s funds individually or in the aggregate were significant products of Carlyle. As of December 31, 2015, Vermillion managed
total AUM of only $1.3 billion (which was less than 1% of Carlyle’s total AUM), and AUM continued to decline throughout 2016 due to negative fund performance and investor redemptions, leading to the decision to wind-down the Vermillion
funds and the operations of Vermillion. Carlyle continues to work on the process for ultimately liquidating the Vermillion business.
Carlyle advises the
Staff that $175 million2 of contingent losses related to a fund and two commodities investment vehicles associated with Vermillion were separately recognized after the decision in the third
quarter of 2016 to liquidate all of the Vermillion funds and wind down the operations of Vermillion. As disclosed in the Legal Matters section of Note 11 to the consolidated financial statements, a hedge fund and two structured finance vehicles
managed by an affiliate of Carlyle invested approximately $400 million in petroleum commodities that Carlyle believes were misappropriated by third parties outside of the U.S. In future filings, Carlyle will revise this disclosure in Note 11 to
clarify that the affiliate managing the vehicles in question is Vermillion. Although Carlyle is pursuing various efforts on behalf of these investment vehicles to recover the losses incurred, the amount and timing of recovery is uncertain. In
December 2016, Carlyle repurchased investor interests in the hedge fund for $100 million, settling potential claims against Carlyle. While other investors have asserted claims related to these matters and Carlyle could incur additional costs or
liabilities in excess of the $175 million in charges already recorded as of December 31, 2016, it was not able to estimate the reasonably possible amount of loss or range of loss in excess of amounts accrued. Carlyle will continue to
reassess this loss contingency each period and in future filings will continue to include all disclosures required by ASC 450 in relation thereto.
Excluding the $175 million of charges related to the legal matter disclosed in Note 11 to the Consolidated Financial Statements in Item 8. and discussed
in Item 7. MD&A – Global Market
2
The $175 million in contingent losses recognized with respect to the Vermillion commodities business was part of a $150 million net contingent loss recognized within the GMS segment, after taking into account a $25
million insurance recovery.
3
Securities and Exchange Commission
Strategies in Carlyle’s Form 10-K for the Fiscal Year Ended
December 31, 2016, Vermillion was not material to Carlyle’s revenues and income from continuing operations in 2016, and Carlyle does not believe the absence of Vermillion will be a material driver of the consolidated changes in revenues or
income from continuing operations when comparing 2017 to 2016 results. However, Carlyle will disclose in future annual and quarterly filings how the wind down of Vermillion impacts revenues and expenses for the Global Market Strategies segment if
significant.
Non-GAAP Financial Measures, page 109
3.
We note on page 110 that you present a full non-GAAP income statements along with corresponding reconciliations of income (loss) before provision for income taxes to economic
income, to fee related earnings, and distributable earnings for each of the years ended December 31, 2016, 2015 and 2014. Please tell us how your presentation and related reconciliation(s) complies with Questions 104.04 and 102.10 of the
updated Non-GAAP Financial Measures Compliance and Disclosure Interpretations issued on May 17, 2016 (the “updated Non-GAAP C&DI”).
Carlyle acknowledges the Staff’s comment and advises the Staff that in future filings it will revise the presentation of the
information beginning on page 110 of the Form 10-K, updated as appropriate, in the manner set forth on Annex A to this letter so that it does not resemble a full
non-GAAP income statement.
Form 8-K Filed February 8, 2017
Exhibit 99.2
4.
We note your presentation of economic net income per adjusted unit and distributable earnings per common unit for the fourth quarter and full year 2016 periods. Please tell us whether you consider these to be
liquidity measures and why you believe presenting them on a per share basis complies with Question 102.05 of the updated Non-GAAP C&DI.
Carlyle advises the Staff that it considers each of economic net income per adjusted unit and distributable earnings per common unit to be performance
measures and not liquidity measures. As disclosed on pages 94-95 in the Form 10-K, Economic Net Income or “ENI” is a key performance measure used in
Carlyle’s industry that provides investors with a meaningful indication of its core operating performance, and Distributable Earnings or “DE” is a performance measure used in Carlyle’s industry intended to show net realized
earnings without the effects of consolidation of the Consolidated Funds and is used by Carlyle to assess performance, as well as for budgeting, forecasting and the overall management of its segments. Both measures are derived from the income
statement and do not measure cash generated. While Distributable Earnings is intended to measure performance on a basis that excludes the effects of unrealized Performance Fees and the related compensation expense and unrealized Investment income
(loss), neither Distributable Earnings nor Economic Net Income in any way seeks, nor is either capable of being used, to measure liquidity. For example, because both measures are derived from the income statement and are used to assess performance,
the significant impacts upon liquidity associated with changes in accounts payable, accrued expenses and other liabilities, as well as from investment and financing activities, are not reflected by such
4
Securities and Exchange Commission
measures. To illustrate, Carlyle’s consolidated net cash flows provided by (used in) operating
activities for the year ended December 31, 2016 was ($300.6 million), in contrast to Distributable Earnings of $651.7 million for the same period. Furthermore, while Carlyle uses Distributable Earnings as a measure to help inform the
amount of earnings to distribute to unitholders each quarter, distributions declared are at the sole discretion of Carlyle’s general partner under its distribution policy after considering a variety of factors, including but not limited to,
Carlyle’s performance and its current and forecasted liquidity. For example, in the fourth quarter of 2016, Carlyle did not generate material Distributable Earnings yet Carlyle’s general partner declared a distribution of $0.16 per common
unit.
* * * * * * * * * * * * * * * *
5
Securities and Exchange Commission
Please do not hesitate to call Joshua Ford Bonnie at (202)
636-5804 with any questions or further comments you may have regarding this filing or if you wish to discuss the above responses.
Very truly yours,
/s/ Simpson Thacher & Bartlett LLP
SIMPSON THACHER & BARTLETT LLP
cc:
Securities and Exchange Commission
Robert Klein
The Carlyle Group L.P.
Curtis L. Buser
Jeffrey W. Ferguson
6
Annex A
Non-GAAP Financial Measures
The following tables set forth information in the format used by management when making resource deployment decisions and in assessing
performance of our segments. These non-GAAP financial measures are presented for the years ended December 31, 2016, 2015 and 2014. The tables below show our total segment revenues, our total segment
expenses and our total segment Economic Net Income which is the sum of Fee Related Earnings, Net Performance Fees, Investment Income (Loss), Reserve for Litigation and Contingencies and Equity-based compensation expense (excluding equity-based
compensation grants issued in May 2012 upon the completion of the initial public offering or grants issued in acquisitions or strategic investments). Our Non-GAAP financial measures exclude the effect of
consolidated funds, acquisition-related items including amortization and any impairment charges of acquired intangible assets and contingent consideration taking the form of earn-outs, charges associated with equity-based compensation grants issued
in May 2012 upon completion of the initial public offering or grants issued in acquisitions or strategic investments, changes in the tax receivable agreement liability, corporate actions and infrequently occurring or unusual events.
The following table sets forth our total segment revenues for the years ended December 31, 2016, 2015 and 2014.
Year Ended December 31,
2016
2015
2014
(Dollars in millions)
Segment Revenues
Fund level fee revenues
Fund management fees
$
1,085.8
$
1,197.9
$
1,229.3
Portfolio advisory fees, net
16.6
15.4
20.1
Transaction fees, net
31.2
9.8
53.2
Total fund level fee revenues
1,133.6
1,223.1
1,302.6
Performance Fee
Realized
1,215.8
1,434.8
1,323.7
Unrealized
(464.1
)
(525.1
)
384.2
Total performance fees
751.7
909.7
1,707.9
Investment income (loss)
Realized
44.9
(64.8
)
(6.1
)
Unrealized
5.4
42.4
(5.0
)
Total investment income (loss)
50.3
(22.4
)
(11.1
)
Interest income
10.2
4.8
2.2
Other income
12.8
17.2
20.4
Total Segment Revenues
1,958.6
2,132.4
3,022.0
The following table sets forth our total segment expenses for the yea